← Leaderboards
Elizabeth Joanna Tarling
University Of California Los Angeles
$6,410,967
Attributed
$9,976,394
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2013–25$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,976,394 · 7
By mechanism
R01$9,055,855 · 5
R00$739,617 · 1
K99$180,922 · 1
Top collaborators
- Thomas A Vallim12 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Tamer Sallam$10,795,420
- Peter A Edwards$10,102,590
- Thomas A Vallim$9,550,774
- Peter J Tontonoz$38,870,418
- Judith A Berliner$11,393,135
Others in their field
Top investigators on “Public Health”
- David R. Weir · University Of Michigan At Ann Arbor$416,847,438
- Jeffrey P Krischer · University Of South Florida$337,395,475
- Wafaa M. El-Sadr · Columbia University Health Sciences$336,205,398
- Elisabeth H Lyman · California St Dept Of Hlth Srvs-Sacramen$325,795,604
- Myron S Cohen · Family Health International$295,773,363
- George R Seage · Abt Associates, Inc.$292,142,010
Research focus
Public HealthLipidsIn VivoLiverMediatingCardiovascular DiseasesHepaticMolecularGenesPathway InteractionsCause Of DeathCholesterolPlasmaAtherosclerosisLipid MetabolismLoss Of FunctionRegulationProteinsClustered Regularly Interspaced Short Palindromic RepeatsCholesterol HomeostasisHealth SystemAffectMetabolismTherapeutic Intervention
Grant awards (22)
Post-transcriptional regulation of hepatokines and systemic metabolism$786,216
R01 · FY2025 · DK
Post-transcriptional regulation of LDLR$773,004
R01 · FY2025 · HL · contact PI
Targeting the gut-liver axis in cardiovascular disease$745,258
R01 · FY2025 · HL
Post-transcriptional regulation of LDLR$100,813
R01 · FY2025 · HL · contact PI
Post-transcriptional regulation of LDLR$777,112
R01 · FY2024 · HL · contact PI
Targeting the gut-liver axis in cardiovascular disease$730,352
R01 · FY2024 · HL
ATP Binding Cassette Transporters in Health and Disease$583,814
R01 · FY2024 · DK · contact PI
Diversity Supplement for âPost-translational regulation of LDLRâ$64,611
R01 · FY2024 · HL · contact PI
Targeting the gut-liver axis in cardiovascular disease$745,258
R01 · FY2023 · HL
ATP Binding Cassette Transporters in Health and Disease$608,139
R01 · FY2023 · DK · contact PI
ATP Binding Cassette Transporters in Health and Disease$608,139
R01 · FY2022 · DK · contact PI
ATP Binding Cassette Transporters in Health and Disease$608,139
R01 · FY2021 · DK · contact PI
Post-Translational Regulation of Lipid Metabolism$385,000
R01 · FY2021 · HL · contact PI
Post-Translational Regulation of Lipid Metabolism$385,000
R01 · FY2020 · HL · contact PI
Post-Translational Regulation of Lipid Metabolism$385,000
R01 · FY2019 · HL · contact PI
Post-Translational Regulation of Lipid Metabolism$385,000
R01 · FY2018 · HL · contact PI
Post-Translational Regulation of Lipid Metabolism$385,000
R01 · FY2017 · HL · contact PI
Role of ABCG1 in lipid homeostasis, inflammation and innate immunity$244,078
R00 · FY2017 · HL · contact PI
Role of ABCG1 in lipid homeostasis, inflammation and innate immunity$246,539
R00 · FY2016 · HL · contact PI
Role of ABCG1 in lipid homeostasis, inflammation and innate immunity$249,000
R00 · FY2015 · HL · contact PI
Role of ABCG1 in lipid homeostasis, inflammation and innate immunity$90,461
K99 · FY2014 · HL · contact PI
Role of ABCG1 in lipid homeostasis, inflammation and innate immunity$90,461
K99 · FY2013 · HL · contact PI